New York Hospitals Studying Heartburn Drug With Hydroxychloroquine Against COVID-19

Medical personnel move a deceased patient to a refrigerated truck serving as a makeshift morgue at Brooklyn Hospital Center in New York City, on April 9, 2020. Angela Weiss/AFP/Getty Images

Some hospitals in New York are conducting a clinical trial testing the efficacy of famotidine, a common heartburn drug, along with the anti-malarial drug hydroxychloroquine against COVID-19.

The randomized, controlled, and double-blind trial is looking at the safety and effectiveness of hydroxychloroquine alone and in combination with famotidine for treating COVID-19 in hospitalized patients.